Pricing and Market Access Considerations for Cell and Gene
… ... An Overview of Cell and Gene Therapies
… ... Two Labs Acquires CEEK Enterprises
… ... Two Labs Acquires CEEK Enterprises
… ... What manufacturers need to know about Minnesota House Bill 400
… ... New regulation requirements impacting your license
… ... Current and Future Oncology Management in the United States
Originally posted by the Journal of Managed Care & Specialty Pharmacy
Volume 25 Issue (2)
Anne Runyan, BA; Jordan Banks, MPA; and Daniele Severi Bruni, MS
MKO Global Partners, Powell, Ohio.
Abstract
BACKGROUND:
Current and Future Oncology Management in the United States
… ... Innovative Access Agreements
… ... NHS England targeting £150 million in savings through rapid adoption of biosimilar adalimumab
With the recent patent expiry of Humira® (adalimumab) in Europe, NHS England last week published a press release reiterating their goal of realizing £300 million in annual savings through the adoption of best value biologic medicines (originator or biosimilar) by … ...